TSCAN THERAPEUTICS, INC. (TCRX) Operating margin 2020–2025
TSCAN THERAPEUTICS, INC. (TCRX) operating margin by fiscal year — reported operating income divided by reported revenue.
-1315.4%FY2025 · since FY2020: -2417.8% → -1315.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1315.4% | +3472.3 pp |
| FY2024 | -4787.7% | -4343.7 pp |
| FY2023 | -444.0% | +48.3 pp |
| FY2022 | -492.3% | -12.7 pp |
| FY2021 | -479.6% | +1938.1 pp |
| FY2020 | -2417.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TCRX financial trends
TCRX RevenueTCRX Net incomeTCRX Net marginTCRX Gross profitTCRX Gross marginTCRX Operating incomeTCRX Operating cash flowTCRX Free cash flowTCRX Capital expendituresTCRX Return on equityTCRX Stock buybacksTCRX Dividends paidTCRX Total assetsTCRX Total liabilitiesTCRX Shareholders’ equityTCRX overview →